To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03972488
Title Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET (NETTER-2)
Acronym NETTER-2
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Advanced Accelerator Applications
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries USA | NLD | ITA | GBR | FRA | ESP | DEU | CAN


No variant requirements are available.